Abstract
The activity of urinary N‐acetylamino‐transferase was determined by high‐performance liquid chro‐matographic assay of acetylisoniazid and isoniazid after administration of isoniazid to healthy Japanese male and bladder cancer patients in Japan. The healthy subjects were 47 college students and 44 company employees ranging from 18 to 64 years old (mean±SD=34.5±13.7). The bladder cancer group consisted of 58 male and 13 female patients, ranging from 28 to 82 years old (mean±SD =60.8 ±11.6), who were being treated at several hospitals. The slow phenotype, defined as an acetylation ratio (acetylisoniazid/isoniazid) of less than 2.0, was observed in 13 (14.3%) of the 91 healthy subjects, and in 20 (28.2%) of the 71 bladder cancer patients; the difference between the two groups is significant (P < 0.05). A histogram of the acetylation ratio values showed an overall leftward shift of the patient group, indicating low values of acetylation ratio in this group as a whole (P < 0.01).
Keywords: N‐Acetyltransferase phenotype, Japanese healthy men, Bladder cancer, AcINH/INH ratio
Full Text
The Full Text of this article is available as a PDF (176.1 KB).
REFERENCES
- 1. ) Lower , G. M. , Jr. , Nilsson , T. , Nelson , C. E. , Wolf , H. , Gamsky , T. E. and Bryan , T. E.N‐Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology . Environ. Health Perspect. , 20 , 71 – 79 ( 1979. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. ) Evans , D. P. , Manley , K. A. and McKusic , V. A.Genetic control of isoniazid metabolism in man . Br. Med. J. , 13 , 485 – 491 ( 1960. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. ) Klark , D. W. J.Genetically determined variability in acetylation and oxidation ‐ therapeutic implications . Drugs , 29 , 342 – 375 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Meyer , U. A.Genetic polymorphism of drugs metabolism . Fundam. Clin. Pharmacol. , 4 , 595 – 615 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Sunahara , S.Clinical findings of INH . Bull. Jpn. Soc. Tuberc. , 36 , 521 – 527 ( 1961. ) ( in Japanese ). [Google Scholar]
- 6. ) Sunahara , S. , Urano , M. and Ogawa , M.Genetic and geographic studies on isoniazid inactivation . Science , 134 , 1530 ( 1961. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Evans , D. A. P. , Eze , L. C. and Whisbley , J.The association of the slow acetylator phenotype with bladder cancer . J. Med. Genet. , 20 , 330 – 333 ( 1983. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Cartwright , R. A. , Glashan , R. W. , Rogers , H. A. , Ahmad , R. A. , Barham‐Hall , D. , Higgins , E. and Kahn , M. A.Role of N‐acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer . Lancet , ii , 842 – 845 ( 1982. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Mommsen , S. and Aagaad , J.Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors . Cancer Lett. , 32 , 199 – 205 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Sone , S.Determination of N‐acetyltransferase phenotype in urothelial cancer patients and healthy controls . Acta Urol. , 32 , 1085 – 1092 ( 1986. ). [PubMed] [Google Scholar]
- 11. ) Horai , Y. , Fujita , K. and Ishizaki , T.Genetically determined N‐acetylation and oxidation capacities in Japanese patients with non‐occupational urinary bladder cancer . Eur. J. Clin. Pharmacol , 37 , 581 – 587 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Svensson , J.‐O. , Muchtar , A. and Erisson , O.Ion‐pair high performance liquid chromatographic determination of isoniazid and acetylisoniazid in plasma and urine . J. Chromatogr. , 341 , 193 – 197 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 13. ) Hayashi , O. , Hashida , C. and Ishizu , S.Determination of AcINH/INH ratio by HPLC . Jpn. J. Hyg. , 47 , 295 ( 1992. ). [Google Scholar]
- 14. ) Horai , Y. and Ishizaki , T.N‐Acetylation polymorphisms of dapsone in a Japanese population . Br. J. Clin. Pharmcol. , 25 , 487 – 494 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. ) Miller , M. E. and Cosgriff , J. M.Acetylator phenotype in human bladder cancer . J. Urol , 130 , 65 – 66 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Motanosky , G. M. and Elliot , E. A.Bladder cancer epidemiology . Epidemiol. Rev. , 3 , 203 – 229 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Hein , D. W. , Rustan , T. D. , Doll , M. A. , Bucher , K. D. , Ferguson , R. A. , Feng , Y. , Furman , E. J. and Gray , K.Acetyltransferase and susceptibility to chemicals . Toxicol. Lett. , 64/65 , 123 – 130 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 18. ) Philip , P. A. , Gayed , S. L. , Rogers , H. J. and Crome , P.Influence of age, sex and body weight on the dapsone acetylation phenotype . Br. J. Clin. Pharmacol. , 23 , 709 – 713 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]